| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Alnylam Pharmaceuticals, Inc. (ALNY) have been net sellers, shedding 1,758 shares worth roughly $399K on balance. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
On the other side, 1 insider reduced a position over the period. ALNY sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 95.8K | - | - | |
| CFO | 64.0K | $20.50M | - | |
| VP | 34.3K | $11.17M | - | |
| VP | 20.7K | $6.73M | - | |
| VP | 19.2K | $6.23M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sell | 2,206 | $327.65 | $722,800.78 | -3.3% | -9.1% | - | |
| Mar 2, 2026 | Greenstreet Yvonne49 | Chief Executive Officer | Sell | 6,799 | $327.65 | $2,227,698.49 | -6.4% | -9.1% | - | |
| Mar 2, 2026 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sell | 1,598 | $327.65 | $523,583.78 | -4.2% | -9.1% | - | |
| Feb 27, 2026 | Garg Pushkal50 | EVP Chief R&D | Sale+OE | 4,627 | $331.34 | $1,533,099.58 | -17.3% | -8.4% | - | |
| Feb 17, 2026 | Fitzgerald Kevin Joseph | CSO &EVP, Head Of Research | Sell | 4,000 | $321.24 | $1,284,979.87 | -15.8% | -13.9% | - | |
| Feb 13, 2026 | Garg Pushkal50 | EVP Chief R&D | Sell | 2,242 | $310.08 | $695,201.15 | -8.3% | -6.7% | - | |
| Feb 13, 2026 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sell | 1,959 | $310.08 | $607,448.29 | -5.8% | -6.7% | - | |
| Feb 13, 2026 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sell | 2,242 | $310.08 | $695,201.15 | -3.6% | -6.7% | - | |
| Feb 13, 2026 | Greenstreet Yvonne49 | Chief Executive Officer | Sell | 6,958 | $310.08 | $2,157,542.21 | -7.5% | -6.7% | - | |
| Jan 13, 2026 | Fitzgerald Kevin Joseph | CSO &EVP, Head Of Research | Sell | 2,951 | $369.60 | $1,090,682.89 | -12.2% | -10.0% | - |